Denmark: DanCann Pharma to acquire CannGros in Nordic’s first medical cannabis M&A

DanCann Pharma,  a Danish pharmaceutical company powered by cannabinoids, and CannGros, an approved manufacturer of cannabis products for medical use. DanCann will acquire 100% of the shares of CannGros. It is the first medical cannabis M&A in the Nordic region. Through the acquisition, DanCann obtains all necessary licenses for the import and distribution of medical…

You must be a HMI Subscriber to view this content.

Subscribe Now »